This article is more than 5 years old. Information may no longer be current.
Perspectives from ASCO 2015: A HemOnc Today Special Report
Click Here to Manage Email Alerts
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”
As such, meeting organizers selected roughly 4,800 abstracts for presentation based on their potential to offer insights that enhance patient care, improve quality of life or inform future research.
“We need to be diverse in the types of research we present, as well as the types of information — not only scientific aspects, but also on the quality of care and value situation,” Julie M. Vose, MD, MBA, FASCO, president of ASCO and chief of the oncology/hematology division at University of Nebraska Medical Center, told HemOnc Today. “As we continue to diversify, that will increase our knowledge for all patients.”
Meeting organizers also emphasized a patient-centered focus and the importance of viewing results in the context of the value proposition.
“The greatest challenge is trying to match the right treatment with the right patient,” Vose said. “In the past, we used the same types of therapies for all of our patients in different modalities. What we need to do is use prognostic models, biomarkers and genetic analysis to really pick the patients for different therapies. That will make it much more cost-effective because the response rate will be much higher.”
This HemOnc Today supplement provides an overview of some of the most compelling research presented at ASCO, along with a series of expert Perspectives designed to put the results in context. — From the Publisher
